Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iodine Radioisotopes | 84 | 2012 | 1031 | 3.240 |
Why?
|
Idoxuridine | 41 | 2012 | 111 | 2.210 |
Why?
|
Nuclear Medicine | 10 | 2014 | 237 | 1.350 |
Why?
|
Radioisotopes | 32 | 2011 | 499 | 1.290 |
Why?
|
Electrons | 27 | 2012 | 265 | 0.960 |
Why?
|
DNA Damage | 20 | 2008 | 2449 | 0.840 |
Why?
|
Radiation Injuries | 6 | 2014 | 1189 | 0.770 |
Why?
|
DNA | 36 | 2012 | 7213 | 0.690 |
Why?
|
Radionuclide Imaging | 36 | 2008 | 1972 | 0.650 |
Why?
|
Prodrugs | 7 | 2011 | 261 | 0.630 |
Why?
|
DNA, Superhelical | 6 | 2012 | 51 | 0.560 |
Why?
|
Radiopharmaceuticals | 19 | 2011 | 2650 | 0.550 |
Why?
|
Plasmids | 11 | 2011 | 2269 | 0.510 |
Why?
|
Radiation Dosage | 21 | 2012 | 1958 | 0.480 |
Why?
|
Meningitis | 3 | 2008 | 217 | 0.430 |
Why?
|
Chemistry, Bioinorganic | 1 | 2012 | 1 | 0.420 |
Why?
|
International Educational Exchange | 1 | 2012 | 49 | 0.400 |
Why?
|
Metalloproteins | 1 | 2012 | 101 | 0.390 |
Why?
|
Drug Delivery Systems | 7 | 2009 | 2226 | 0.360 |
Why?
|
Gamma Rays | 21 | 2011 | 318 | 0.360 |
Why?
|
Radiobiology | 3 | 2005 | 90 | 0.350 |
Why?
|
Gliosarcoma | 4 | 1998 | 114 | 0.340 |
Why?
|
Cell Survival | 33 | 2006 | 5791 | 0.340 |
Why?
|
Neoplasms, Experimental | 11 | 2002 | 1229 | 0.330 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 2 | 2000 | 110 | 0.320 |
Why?
|
Zinc | 2 | 2012 | 690 | 0.300 |
Why?
|
Dose-Response Relationship, Radiation | 21 | 2011 | 882 | 0.300 |
Why?
|
Methotrexate | 3 | 2008 | 1719 | 0.300 |
Why?
|
Radiometry | 8 | 2014 | 813 | 0.300 |
Why?
|
Dimethyl Sulfoxide | 8 | 2007 | 251 | 0.300 |
Why?
|
Radiotherapy | 4 | 2005 | 1498 | 0.300 |
Why?
|
Cricetinae | 36 | 2001 | 2423 | 0.290 |
Why?
|
Cells | 2 | 2003 | 165 | 0.280 |
Why?
|
Neoplasms | 24 | 2011 | 22173 | 0.260 |
Why?
|
Radiation Effects | 15 | 1990 | 69 | 0.260 |
Why?
|
Paralysis | 3 | 2004 | 250 | 0.260 |
Why?
|
Financing, Government | 2 | 2004 | 472 | 0.230 |
Why?
|
Nuclear Warfare | 1 | 2004 | 30 | 0.230 |
Why?
|
Phosphorus Radioisotopes | 4 | 1999 | 100 | 0.230 |
Why?
|
Gene Targeting | 2 | 2006 | 838 | 0.230 |
Why?
|
Foundations | 1 | 2004 | 95 | 0.230 |
Why?
|
Linear Energy Transfer | 3 | 2005 | 152 | 0.230 |
Why?
|
Government Agencies | 1 | 2004 | 160 | 0.220 |
Why?
|
Radionuclide Generators | 1 | 2003 | 12 | 0.220 |
Why?
|
Cell Physiological Phenomena | 1 | 2005 | 150 | 0.220 |
Why?
|
Nucleic Acid Conformation | 7 | 2012 | 902 | 0.220 |
Why?
|
Bystander Effect | 3 | 2012 | 90 | 0.210 |
Why?
|
DNA, Single-Stranded | 3 | 1999 | 355 | 0.210 |
Why?
|
Quinazolinones | 5 | 2007 | 221 | 0.210 |
Why?
|
Tissue Distribution | 17 | 2007 | 2264 | 0.210 |
Why?
|
Alkaline Phosphatase | 5 | 2011 | 864 | 0.200 |
Why?
|
Academies and Institutes | 1 | 2004 | 318 | 0.200 |
Why?
|
Hydroxyl Radical | 4 | 2008 | 82 | 0.190 |
Why?
|
Fetus | 2 | 1999 | 1863 | 0.190 |
Why?
|
Health Physics | 1 | 2001 | 32 | 0.190 |
Why?
|
Rhabdomyosarcoma | 2 | 2004 | 358 | 0.190 |
Why?
|
DNA Breaks, Double-Stranded | 3 | 2012 | 613 | 0.180 |
Why?
|
Indium Radioisotopes | 5 | 2000 | 113 | 0.180 |
Why?
|
DNA Breaks, Single-Stranded | 2 | 2011 | 24 | 0.180 |
Why?
|
Cricetulus | 20 | 2001 | 814 | 0.170 |
Why?
|
Benzimidazoles | 6 | 2008 | 858 | 0.170 |
Why?
|
Radiation-Protective Agents | 1 | 2000 | 88 | 0.170 |
Why?
|
Radiation Protection | 6 | 2011 | 424 | 0.160 |
Why?
|
Intercalating Agents | 6 | 1997 | 33 | 0.160 |
Why?
|
Models, Molecular | 8 | 2012 | 5439 | 0.160 |
Why?
|
Animals | 102 | 2014 | 168475 | 0.150 |
Why?
|
Spinal Neoplasms | 1 | 2004 | 716 | 0.150 |
Why?
|
Radioactivity | 5 | 2008 | 59 | 0.150 |
Why?
|
Coumarins | 2 | 2008 | 118 | 0.150 |
Why?
|
Chromatin | 5 | 2000 | 2961 | 0.150 |
Why?
|
Communication | 2 | 2012 | 3875 | 0.150 |
Why?
|
Isotope Labeling | 10 | 2012 | 392 | 0.150 |
Why?
|
Risk | 5 | 2014 | 9610 | 0.140 |
Why?
|
Electrophoresis, Agar Gel | 4 | 2011 | 207 | 0.140 |
Why?
|
Radioimmunodetection | 1 | 1996 | 45 | 0.130 |
Why?
|
Avidin | 1 | 1996 | 43 | 0.130 |
Why?
|
Pediatrics | 1 | 2011 | 3589 | 0.130 |
Why?
|
Research Support as Topic | 2 | 1993 | 697 | 0.130 |
Why?
|
Brain Neoplasms | 8 | 2008 | 9032 | 0.130 |
Why?
|
Microarray Analysis | 2 | 2009 | 750 | 0.130 |
Why?
|
Celiac Disease | 1 | 2003 | 821 | 0.120 |
Why?
|
Injections, Spinal | 4 | 2008 | 318 | 0.120 |
Why?
|
Biotin | 1 | 1996 | 253 | 0.120 |
Why?
|
Neoplasm Transplantation | 10 | 2002 | 2016 | 0.120 |
Why?
|
Sodium Iodide | 3 | 2008 | 11 | 0.120 |
Why?
|
Cell Line | 30 | 2000 | 15601 | 0.120 |
Why?
|
Rhodamines | 4 | 1998 | 178 | 0.120 |
Why?
|
Autoantibodies | 1 | 2003 | 2118 | 0.120 |
Why?
|
DNA, Recombinant | 1 | 1995 | 455 | 0.120 |
Why?
|
Astatine | 6 | 1998 | 10 | 0.120 |
Why?
|
Antibodies, Anticardiolipin | 2 | 2004 | 62 | 0.120 |
Why?
|
Indium | 4 | 1985 | 47 | 0.110 |
Why?
|
Radiation Tolerance | 3 | 2006 | 478 | 0.110 |
Why?
|
Models, Chemical | 2 | 2005 | 611 | 0.100 |
Why?
|
Rats, Inbred F344 | 5 | 1998 | 826 | 0.100 |
Why?
|
Fluorescent Dyes | 3 | 2012 | 1903 | 0.100 |
Why?
|
Radiotherapy Dosage | 7 | 2005 | 2898 | 0.100 |
Why?
|
Ribonucleases | 5 | 1976 | 277 | 0.100 |
Why?
|
Autoradiography | 11 | 2007 | 728 | 0.100 |
Why?
|
Floxuridine | 1 | 1991 | 44 | 0.100 |
Why?
|
Antipyrine | 3 | 1999 | 40 | 0.100 |
Why?
|
Xanthenes | 2 | 1989 | 72 | 0.100 |
Why?
|
Astrocytoma | 1 | 1996 | 775 | 0.090 |
Why?
|
DNA, Circular | 1 | 2011 | 97 | 0.090 |
Why?
|
Half-Life | 5 | 2005 | 651 | 0.090 |
Why?
|
History, 20th Century | 3 | 2012 | 2767 | 0.090 |
Why?
|
Rats | 17 | 2006 | 23741 | 0.090 |
Why?
|
Meningeal Neoplasms | 3 | 2008 | 1248 | 0.090 |
Why?
|
Lymphocytes | 6 | 2012 | 2612 | 0.090 |
Why?
|
Cell Nucleus | 9 | 2008 | 2910 | 0.090 |
Why?
|
Thymidine | 8 | 1987 | 299 | 0.090 |
Why?
|
X-Rays | 4 | 2008 | 307 | 0.090 |
Why?
|
Chromatography, High Pressure Liquid | 6 | 2007 | 1541 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 4 | 2010 | 549 | 0.090 |
Why?
|
Kinetics | 12 | 2011 | 6374 | 0.090 |
Why?
|
Genetic Testing | 1 | 2003 | 3537 | 0.090 |
Why?
|
Fibroblasts | 7 | 2001 | 4142 | 0.080 |
Why?
|
Radiation Genetics | 4 | 1986 | 16 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2004 | 239 | 0.080 |
Why?
|
Dysprosium | 2 | 1986 | 24 | 0.080 |
Why?
|
Humans | 98 | 2014 | 761596 | 0.080 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2000 | 174 | 0.080 |
Why?
|
Spermidine | 1 | 2008 | 62 | 0.080 |
Why?
|
Spermine | 1 | 2008 | 70 | 0.080 |
Why?
|
Hyperthyroidism | 2 | 2001 | 294 | 0.080 |
Why?
|
Computational Biology | 2 | 2011 | 3517 | 0.080 |
Why?
|
Antibodies, Monoclonal | 8 | 2007 | 9177 | 0.080 |
Why?
|
Antibodies, Neoplasm | 4 | 2007 | 281 | 0.080 |
Why?
|
Tritium | 10 | 1982 | 708 | 0.080 |
Why?
|
Hydrolysis | 5 | 2011 | 664 | 0.070 |
Why?
|
Access to Information | 1 | 2011 | 316 | 0.070 |
Why?
|
Gallium Radioisotopes | 2 | 1980 | 195 | 0.070 |
Why?
|
Immunoglobulins | 1 | 1991 | 852 | 0.070 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3617 | 0.070 |
Why?
|
Relative Biological Effectiveness | 3 | 2003 | 312 | 0.070 |
Why?
|
Solutions | 8 | 2008 | 412 | 0.070 |
Why?
|
Ascites | 4 | 1991 | 338 | 0.070 |
Why?
|
Molecular Probes | 1 | 2008 | 309 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2004 | 646 | 0.070 |
Why?
|
Isoenzymes | 1 | 2011 | 1687 | 0.070 |
Why?
|
DNA Repair | 3 | 2008 | 2046 | 0.070 |
Why?
|
Polyamines | 1 | 2007 | 133 | 0.070 |
Why?
|
Databases, Genetic | 2 | 2011 | 1742 | 0.070 |
Why?
|
Diagnostic Imaging | 2 | 2011 | 3530 | 0.070 |
Why?
|
Technetium | 8 | 1989 | 317 | 0.070 |
Why?
|
Injections, Intralesional | 2 | 1998 | 280 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1068 | 0.070 |
Why?
|
Mice, Nude | 9 | 2006 | 3614 | 0.070 |
Why?
|
Proflavine | 3 | 1990 | 7 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 3 | 1999 | 793 | 0.060 |
Why?
|
History, 21st Century | 1 | 2012 | 1567 | 0.060 |
Why?
|
PubMed | 1 | 2006 | 129 | 0.060 |
Why?
|
Quaternary Ammonium Compounds | 2 | 2007 | 202 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2008 | 582 | 0.060 |
Why?
|
Endocytosis | 1 | 1990 | 957 | 0.060 |
Why?
|
Oxyquinoline | 1 | 1985 | 16 | 0.060 |
Why?
|
Hydroxyquinolines | 1 | 1985 | 17 | 0.060 |
Why?
|
Chromium Radioisotopes | 1 | 1985 | 34 | 0.060 |
Why?
|
Extracellular Space | 1 | 2007 | 563 | 0.060 |
Why?
|
Writing | 1 | 1987 | 199 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 457 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 678 | 0.060 |
Why?
|
Rhodamine 123 | 3 | 1989 | 37 | 0.060 |
Why?
|
Molecular Biology | 1 | 2008 | 576 | 0.060 |
Why?
|
Free Radical Scavengers | 3 | 2000 | 211 | 0.060 |
Why?
|
Ethidium | 2 | 2008 | 27 | 0.060 |
Why?
|
Databases, Protein | 1 | 2006 | 387 | 0.060 |
Why?
|
Cells, Cultured | 16 | 2007 | 18966 | 0.060 |
Why?
|
Histones | 2 | 1987 | 2580 | 0.060 |
Why?
|
Ferric Compounds | 1 | 1986 | 378 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2011 | 8554 | 0.060 |
Why?
|
IgA Deficiency | 1 | 2003 | 39 | 0.060 |
Why?
|
Mice | 35 | 2007 | 81539 | 0.060 |
Why?
|
Quality Assurance, Health Care | 2 | 2004 | 2169 | 0.060 |
Why?
|
Immunoglobulin G | 5 | 2007 | 4544 | 0.050 |
Why?
|
Acridines | 3 | 1997 | 19 | 0.050 |
Why?
|
HLA-DQ Antigens | 1 | 2003 | 191 | 0.050 |
Why?
|
Protein Transport | 1 | 2008 | 1967 | 0.050 |
Why?
|
Ovarian Neoplasms | 7 | 2008 | 4878 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2003 | 104 | 0.050 |
Why?
|
Phantoms, Imaging | 1 | 2011 | 2526 | 0.050 |
Why?
|
Synovial Membrane | 1 | 1986 | 532 | 0.050 |
Why?
|
Alpha Particles | 6 | 1988 | 29 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 1996 | 3847 | 0.050 |
Why?
|
Xenon | 5 | 1974 | 112 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2008 | 2496 | 0.050 |
Why?
|
Models, Biological | 7 | 2007 | 9469 | 0.050 |
Why?
|
Culture Media | 3 | 2001 | 897 | 0.050 |
Why?
|
Cell Cycle | 2 | 2008 | 2932 | 0.050 |
Why?
|
Lymph Nodes | 2 | 1986 | 3465 | 0.050 |
Why?
|
Hypertension, Renal | 3 | 1976 | 135 | 0.050 |
Why?
|
Organometallic Compounds | 1 | 1985 | 647 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2319 | 0.050 |
Why?
|
Antigens, Surface | 3 | 1991 | 1606 | 0.050 |
Why?
|
Drug Discovery | 1 | 2009 | 1051 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 66 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 819 | 0.050 |
Why?
|
Prostatic Neoplasms | 6 | 2010 | 11122 | 0.040 |
Why?
|
Pregnancy | 3 | 1999 | 29890 | 0.040 |
Why?
|
Drug Synergism | 1 | 2004 | 1757 | 0.040 |
Why?
|
Laboratories | 1 | 2004 | 458 | 0.040 |
Why?
|
Pulmonary Embolism | 5 | 1978 | 2567 | 0.040 |
Why?
|
Phenylalanine | 5 | 1984 | 366 | 0.040 |
Why?
|
Receptors, Estrogen | 3 | 1984 | 2209 | 0.040 |
Why?
|
Rats, Nude | 1 | 2000 | 105 | 0.040 |
Why?
|
Liver | 12 | 2007 | 7528 | 0.040 |
Why?
|
Nucleosomes | 2 | 1998 | 488 | 0.040 |
Why?
|
Tuberculosis, Meningeal | 1 | 1980 | 47 | 0.040 |
Why?
|
Ribonuclease, Pancreatic | 2 | 1974 | 149 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3810 | 0.040 |
Why?
|
Japan | 1 | 2004 | 1378 | 0.040 |
Why?
|
Adenocarcinoma | 4 | 2006 | 6345 | 0.040 |
Why?
|
Octreotide | 1 | 2000 | 153 | 0.040 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1981 | 294 | 0.040 |
Why?
|
Apoptosis | 2 | 2006 | 9490 | 0.040 |
Why?
|
Solubility | 3 | 2007 | 1091 | 0.040 |
Why?
|
Binding Sites | 5 | 2011 | 6056 | 0.040 |
Why?
|
Dactinomycin | 2 | 1971 | 304 | 0.040 |
Why?
|
Tumor Cells, Cultured | 7 | 2007 | 6131 | 0.040 |
Why?
|
Mass Screening | 3 | 1981 | 5429 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4016 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 3 | 1996 | 2223 | 0.040 |
Why?
|
Carcinoma | 2 | 2008 | 2330 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2000 | 320 | 0.040 |
Why?
|
Thymidine Kinase | 4 | 1990 | 286 | 0.040 |
Why?
|
Education, Medical | 1 | 1991 | 1725 | 0.040 |
Why?
|
Cell Line, Tumor | 7 | 2012 | 16990 | 0.040 |
Why?
|
Radioisotope Renography | 2 | 1975 | 61 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2004 | 746 | 0.040 |
Why?
|
S Phase | 1 | 2000 | 421 | 0.040 |
Why?
|
Free Radicals | 3 | 1987 | 238 | 0.040 |
Why?
|
Biophysics | 1 | 2000 | 380 | 0.040 |
Why?
|
Oxidoreductases | 4 | 1963 | 413 | 0.040 |
Why?
|
Lung | 10 | 2000 | 10002 | 0.040 |
Why?
|
Evaluation Studies as Topic | 4 | 2011 | 1625 | 0.040 |
Why?
|
United States | 9 | 2012 | 72340 | 0.040 |
Why?
|
Chromosome Aberrations | 4 | 1986 | 1768 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2012 | 10451 | 0.040 |
Why?
|
Costs and Cost Analysis | 4 | 1978 | 1668 | 0.040 |
Why?
|
Tamoxifen | 5 | 1984 | 965 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2008 | 2557 | 0.040 |
Why?
|
Activation Analysis | 1 | 1977 | 3 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2008 | 8527 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1406 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4425 | 0.040 |
Why?
|
International Cooperation | 1 | 2004 | 1422 | 0.040 |
Why?
|
Radiology | 2 | 1993 | 2113 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 350 | 0.040 |
Why?
|
Mice, Inbred C3H | 4 | 2006 | 915 | 0.040 |
Why?
|
Coronary Circulation | 2 | 1974 | 1569 | 0.040 |
Why?
|
Models, Theoretical | 5 | 2000 | 3575 | 0.040 |
Why?
|
Methods | 6 | 1977 | 1067 | 0.040 |
Why?
|
Politics | 1 | 2004 | 815 | 0.040 |
Why?
|
Genetic Markers | 1 | 2003 | 2601 | 0.040 |
Why?
|
Glutamate Dehydrogenase | 3 | 1965 | 50 | 0.040 |
Why?
|
Urography | 2 | 1975 | 316 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 2 | 1989 | 71 | 0.040 |
Why?
|
Iron | 1 | 1986 | 1793 | 0.040 |
Why?
|
Decision Making | 4 | 2001 | 3929 | 0.040 |
Why?
|
Iodine Compounds | 1 | 1996 | 28 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 1998 | 561 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 1999 | 461 | 0.030 |
Why?
|
Drug Design | 3 | 2007 | 1048 | 0.030 |
Why?
|
Colonic Neoplasms | 3 | 2008 | 2539 | 0.030 |
Why?
|
Bronchial Neoplasms | 1 | 1977 | 110 | 0.030 |
Why?
|
Heart Function Tests | 1 | 1977 | 318 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 1979 | 401 | 0.030 |
Why?
|
Transplantation, Heterologous | 4 | 2002 | 2386 | 0.030 |
Why?
|
Water | 6 | 2008 | 1411 | 0.030 |
Why?
|
Spleen | 7 | 1990 | 2295 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9420 | 0.030 |
Why?
|
Role | 2 | 1989 | 176 | 0.030 |
Why?
|
Computer Simulation | 2 | 2007 | 6241 | 0.030 |
Why?
|
Streptavidin | 1 | 1996 | 82 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2003 | 1301 | 0.030 |
Why?
|
Research | 4 | 1965 | 1982 | 0.030 |
Why?
|
Microscopy, Fluorescence | 4 | 2006 | 2645 | 0.030 |
Why?
|
Periodontal Diseases | 2 | 1978 | 451 | 0.030 |
Why?
|
Hypothyroidism | 1 | 1981 | 668 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1998 | 555 | 0.030 |
Why?
|
Amino Acids | 7 | 1987 | 1718 | 0.030 |
Why?
|
Insulinoma | 3 | 1991 | 121 | 0.030 |
Why?
|
NAD | 3 | 1965 | 614 | 0.030 |
Why?
|
Alveolar Process | 2 | 1978 | 294 | 0.030 |
Why?
|
Quinazolines | 1 | 2002 | 1371 | 0.030 |
Why?
|
Thyroid Function Tests | 2 | 1981 | 288 | 0.030 |
Why?
|
Glioma | 1 | 1990 | 3455 | 0.030 |
Why?
|
Cell Separation | 2 | 1984 | 1720 | 0.030 |
Why?
|
Methionine | 8 | 1980 | 572 | 0.030 |
Why?
|
Heart Diseases | 4 | 1977 | 2781 | 0.030 |
Why?
|
Dog Diseases | 1 | 1975 | 141 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6484 | 0.030 |
Why?
|
Radioimmunoassay | 2 | 1988 | 861 | 0.030 |
Why?
|
Crystallography, X-Ray | 2 | 2011 | 1990 | 0.030 |
Why?
|
Diagnosis | 1 | 1975 | 157 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2000 | 2827 | 0.030 |
Why?
|
False Positive Reactions | 5 | 1978 | 957 | 0.030 |
Why?
|
Thallium | 3 | 1984 | 100 | 0.030 |
Why?
|
Spinal Cord | 2 | 2000 | 1819 | 0.030 |
Why?
|
Research Personnel | 1 | 1999 | 588 | 0.030 |
Why?
|
Neuroendocrine Tumors | 1 | 2000 | 641 | 0.030 |
Why?
|
Binding Sites, Antibody | 2 | 1991 | 337 | 0.030 |
Why?
|
Leucovorin | 1 | 1996 | 643 | 0.030 |
Why?
|
Oxidation-Reduction | 3 | 1987 | 2231 | 0.030 |
Why?
|
Potassium Isotopes | 1 | 1973 | 9 | 0.030 |
Why?
|
Platinum | 2 | 1994 | 220 | 0.030 |
Why?
|
Subcellular Fractions | 2 | 1987 | 532 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2371 | 0.030 |
Why?
|
Cobalt Radioisotopes | 6 | 1992 | 75 | 0.030 |
Why?
|
Brachytherapy | 1 | 1981 | 1223 | 0.030 |
Why?
|
Child | 2 | 2012 | 80158 | 0.030 |
Why?
|
Chelating Agents | 1 | 1995 | 387 | 0.030 |
Why?
|
Protons | 2 | 1977 | 1116 | 0.030 |
Why?
|
Cell Division | 4 | 2002 | 4465 | 0.030 |
Why?
|
DNA Fragmentation | 2 | 2006 | 237 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2012 | 72 | 0.030 |
Why?
|
Puromycin | 1 | 1971 | 42 | 0.030 |
Why?
|
Chemistry | 3 | 1990 | 347 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2012 | 86 | 0.020 |
Why?
|
Glutamates | 2 | 1965 | 389 | 0.020 |
Why?
|
Teratoma | 1 | 1975 | 404 | 0.020 |
Why?
|
Chemical Phenomena | 3 | 1990 | 507 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 1981 | 1420 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 151 | 0.020 |
Why?
|
Glucagon | 2 | 1984 | 532 | 0.020 |
Why?
|
Bromine | 2 | 1982 | 23 | 0.020 |
Why?
|
Kupffer Cells | 1 | 1992 | 143 | 0.020 |
Why?
|
Immunoglobulin M | 2 | 2004 | 1526 | 0.020 |
Why?
|
Selenium | 6 | 1980 | 417 | 0.020 |
Why?
|
Time Factors | 12 | 1998 | 39969 | 0.020 |
Why?
|
Risk Assessment | 3 | 2010 | 23996 | 0.020 |
Why?
|
Mitochondria, Liver | 1 | 1971 | 190 | 0.020 |
Why?
|
Static Electricity | 1 | 2011 | 261 | 0.020 |
Why?
|
Literature, Modern | 1 | 2011 | 30 | 0.020 |
Why?
|
Female | 32 | 2008 | 392705 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 1991 | 340 | 0.020 |
Why?
|
Fluorouracil | 1 | 1996 | 1642 | 0.020 |
Why?
|
Radiochemistry | 2 | 2007 | 49 | 0.020 |
Why?
|
Radiography | 5 | 2010 | 6965 | 0.020 |
Why?
|
False Negative Reactions | 3 | 1976 | 573 | 0.020 |
Why?
|
Gangliosides | 1 | 1991 | 132 | 0.020 |
Why?
|
Ethanol | 1 | 1976 | 1324 | 0.020 |
Why?
|
Australia | 2 | 2004 | 1250 | 0.020 |
Why?
|
Fluorescence | 2 | 2002 | 756 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1986 | 3763 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 398 | 0.020 |
Why?
|
Liver Neoplasms | 2 | 1996 | 4317 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 470 | 0.020 |
Why?
|
Hydroxides | 2 | 1998 | 46 | 0.020 |
Why?
|
Freezing | 2 | 2001 | 311 | 0.020 |
Why?
|
Physician's Role | 2 | 1989 | 917 | 0.020 |
Why?
|
Rubidium | 3 | 1983 | 122 | 0.020 |
Why?
|
Catalysis | 1 | 2011 | 774 | 0.020 |
Why?
|
Cryoprotective Agents | 2 | 2001 | 128 | 0.020 |
Why?
|
India | 3 | 1981 | 2348 | 0.020 |
Why?
|
Radiation Monitoring | 1 | 1990 | 103 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1990 | 1741 | 0.020 |
Why?
|
Spirometry | 1 | 1973 | 929 | 0.020 |
Why?
|
Lung Diseases | 3 | 1976 | 1909 | 0.020 |
Why?
|
Palliative Care | 1 | 2004 | 3598 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2011 | 705 | 0.020 |
Why?
|
Protein Conformation | 2 | 1987 | 3968 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1996 | 783 | 0.020 |
Why?
|
Sciuridae | 2 | 1970 | 78 | 0.020 |
Why?
|
Antineoplastic Agents | 4 | 1998 | 13642 | 0.020 |
Why?
|
Titrimetry | 1 | 2008 | 35 | 0.020 |
Why?
|
Ligands | 2 | 2007 | 3272 | 0.020 |
Why?
|
Exonucleases | 1 | 2008 | 44 | 0.020 |
Why?
|
Cisplatin | 1 | 1994 | 1652 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2008 | 138 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1980 | 1922 | 0.020 |
Why?
|
Pancreatic Neoplasms | 4 | 2008 | 5368 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8833 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8225 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20568 | 0.020 |
Why?
|
Succinimides | 1 | 1987 | 81 | 0.020 |
Why?
|
Fibrosarcoma | 1 | 1989 | 309 | 0.020 |
Why?
|
Rabbits | 4 | 1991 | 4772 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36426 | 0.020 |
Why?
|
Nucleosides | 1 | 1968 | 131 | 0.020 |
Why?
|
Developing Countries | 1 | 1980 | 2885 | 0.020 |
Why?
|
Dithioerythritol | 1 | 1987 | 8 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 1791 | 0.020 |
Why?
|
Iodine Isotopes | 1 | 2007 | 79 | 0.020 |
Why?
|
Angiography | 4 | 1978 | 1595 | 0.020 |
Why?
|
Male | 23 | 2010 | 360846 | 0.020 |
Why?
|
Acetic Acid | 1 | 1987 | 60 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2007 | 139 | 0.020 |
Why?
|
Energy Transfer | 3 | 1989 | 108 | 0.020 |
Why?
|
Lung Neoplasms | 4 | 2008 | 13381 | 0.020 |
Why?
|
Beta Particles | 1 | 1987 | 51 | 0.020 |
Why?
|
Bone and Bones | 1 | 1977 | 2568 | 0.020 |
Why?
|
Cost-Benefit Analysis | 4 | 1981 | 5493 | 0.020 |
Why?
|
Copper | 2 | 1961 | 369 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15843 | 0.020 |
Why?
|
Cardiovascular Diseases | 4 | 1975 | 15502 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 947 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 999 | 0.020 |
Why?
|
Melanoma | 1 | 2005 | 5709 | 0.020 |
Why?
|
Pulmonary Circulation | 3 | 1974 | 737 | 0.020 |
Why?
|
Antibody Specificity | 2 | 1987 | 1060 | 0.020 |
Why?
|
Angiocardiography | 2 | 1977 | 149 | 0.020 |
Why?
|
Solvents | 1 | 2007 | 295 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 452 | 0.020 |
Why?
|
Ethics, Medical | 2 | 1989 | 783 | 0.020 |
Why?
|
Iodine | 2 | 1981 | 288 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1967 | 303 | 0.020 |
Why?
|
Physiology, Comparative | 2 | 1970 | 8 | 0.020 |
Why?
|
Indicators and Reagents | 2 | 1998 | 462 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 3076 | 0.020 |
Why?
|
Colorectal Neoplasms | 2 | 1996 | 6938 | 0.020 |
Why?
|
Superoxides | 1 | 1987 | 387 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 2 | 1996 | 221 | 0.020 |
Why?
|
Data Mining | 1 | 2011 | 551 | 0.020 |
Why?
|
Microscopy, Atomic Force | 1 | 2006 | 253 | 0.020 |
Why?
|
Cardiology | 1 | 1976 | 1656 | 0.020 |
Why?
|
Whole-Body Counting | 1 | 2005 | 36 | 0.020 |
Why?
|
Cobalt Isotopes | 1 | 1965 | 5 | 0.020 |
Why?
|
Acetates | 1 | 1987 | 321 | 0.020 |
Why?
|
Carbon Isotopes | 4 | 1971 | 458 | 0.020 |
Why?
|
Fluorometry | 1 | 1965 | 99 | 0.020 |
Why?
|
Enkephalin, Leucine | 1 | 1984 | 16 | 0.020 |
Why?
|
Thermodynamics | 1 | 2006 | 595 | 0.020 |
Why?
|
Ultracentrifugation | 1 | 1965 | 183 | 0.020 |
Why?
|
Database Management Systems | 1 | 2006 | 257 | 0.020 |
Why?
|
Carcinoma, Bronchogenic | 2 | 1976 | 87 | 0.020 |
Why?
|
Terminal Care | 2 | 1989 | 1761 | 0.010 |
Why?
|
Kidney | 4 | 2007 | 7048 | 0.010 |
Why?
|
Systems Integration | 1 | 2006 | 426 | 0.010 |
Why?
|
Dogs | 4 | 1984 | 3839 | 0.010 |
Why?
|
Caspase 3 | 1 | 2006 | 731 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18255 | 0.010 |
Why?
|
Reticulocytes | 1 | 1965 | 289 | 0.010 |
Why?
|
Calcium | 1 | 1977 | 5722 | 0.010 |
Why?
|
Probability | 3 | 1975 | 2477 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1965 | 433 | 0.010 |
Why?
|
Pharmacology | 1 | 1964 | 100 | 0.010 |
Why?
|
Deoxy Sugars | 1 | 1983 | 20 | 0.010 |
Why?
|
Blood Cell Count | 1 | 1965 | 397 | 0.010 |
Why?
|
Radiation, Ionizing | 2 | 1982 | 251 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1965 | 411 | 0.010 |
Why?
|
Maryland | 1 | 1984 | 277 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1835 | 0.010 |
Why?
|
Personnel, Hospital | 2 | 1976 | 285 | 0.010 |
Why?
|
Molecular Imaging | 1 | 2011 | 815 | 0.010 |
Why?
|
Food | 2 | 1959 | 774 | 0.010 |
Why?
|
Fluorine | 1 | 1983 | 83 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2001 | 7391 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1186 | 0.010 |
Why?
|
Escherichia coli | 2 | 2011 | 4217 | 0.010 |
Why?
|
Radiography, Interventional | 1 | 2010 | 1121 | 0.010 |
Why?
|
Amino Acid Oxidoreductases | 1 | 1963 | 149 | 0.010 |
Why?
|
New Zealand | 1 | 2004 | 358 | 0.010 |
Why?
|
Protein Binding | 2 | 2011 | 9353 | 0.010 |
Why?
|
Yttrium Radioisotopes | 1 | 1984 | 107 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 1963 | 169 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1983 | 333 | 0.010 |
Why?
|
Transplantation Immunology | 1 | 1965 | 532 | 0.010 |
Why?
|
Metabolism | 1 | 1964 | 193 | 0.010 |
Why?
|
Potassium Radioisotopes | 2 | 1983 | 12 | 0.010 |
Why?
|
Rodentia | 1 | 1964 | 262 | 0.010 |
Why?
|
Urine | 1 | 1964 | 362 | 0.010 |
Why?
|
Phosphorylases | 1 | 1962 | 17 | 0.010 |
Why?
|
Mice, Inbred Strains | 2 | 1978 | 1762 | 0.010 |
Why?
|
Hospital Administration | 2 | 1976 | 353 | 0.010 |
Why?
|
Clinical Medicine | 1 | 2003 | 145 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3779 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1745 | 0.010 |
Why?
|
Biological Transport | 1 | 1987 | 2091 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1974 | 5112 | 0.010 |
Why?
|
Models, Anatomic | 1 | 1986 | 683 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2008 | 946 | 0.010 |
Why?
|
Chromium Compounds | 1 | 1981 | 7 | 0.010 |
Why?
|
Italy | 1 | 2003 | 842 | 0.010 |
Why?
|
Forecasting | 1 | 1991 | 2928 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2011 | 3396 | 0.010 |
Why?
|
Tellurium | 1 | 1981 | 21 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17904 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 23447 | 0.010 |
Why?
|
Ovary | 1 | 1986 | 959 | 0.010 |
Why?
|
Mitosis | 2 | 1996 | 1188 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 1980 | 113 | 0.010 |
Why?
|
Microspheres | 2 | 1990 | 784 | 0.010 |
Why?
|
Tongue | 1 | 1964 | 403 | 0.010 |
Why?
|
Methylcholanthrene | 1 | 2000 | 31 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1965 | 1596 | 0.010 |
Why?
|
Duodenum | 1 | 1964 | 490 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 1981 | 135 | 0.010 |
Why?
|
Photons | 1 | 2004 | 589 | 0.010 |
Why?
|
Decision Theory | 1 | 1980 | 27 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1971 | 0.010 |
Why?
|
Arteriosclerosis | 2 | 1975 | 1055 | 0.010 |
Why?
|
Models, Immunological | 1 | 2002 | 513 | 0.010 |
Why?
|
Species Specificity | 1 | 1964 | 2414 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 2007 | 22174 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4125 | 0.010 |
Why?
|
Injections, Intravenous | 2 | 1990 | 1379 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1965 | 1176 | 0.010 |
Why?
|
Perfusion | 2 | 1974 | 1373 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2004 | 20100 | 0.010 |
Why?
|
Clone Cells | 2 | 1981 | 1659 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1979 | 166 | 0.010 |
Why?
|
Lymphoma | 1 | 1988 | 1901 | 0.010 |
Why?
|
Pancreas | 2 | 1967 | 1691 | 0.010 |
Why?
|
KB Cells | 1 | 1998 | 13 | 0.010 |
Why?
|
Oxygen Radioisotopes | 1 | 1978 | 75 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1999 | 26202 | 0.010 |
Why?
|
Nitriles | 1 | 1984 | 971 | 0.010 |
Why?
|
Cold Temperature | 2 | 2001 | 785 | 0.010 |
Why?
|
Biological Evolution | 1 | 1964 | 1071 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1998 | 352 | 0.010 |
Why?
|
Molecular Weight | 2 | 1984 | 2186 | 0.010 |
Why?
|
Chromatids | 1 | 1978 | 62 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2004 | 64685 | 0.010 |
Why?
|
Hodgkin Disease | 2 | 1976 | 1378 | 0.010 |
Why?
|
Immunotherapy | 2 | 1991 | 4652 | 0.010 |
Why?
|
Heart | 2 | 1984 | 4404 | 0.010 |
Why?
|
Hibernation | 2 | 1970 | 47 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14665 | 0.010 |
Why?
|
Placenta | 1 | 2007 | 1709 | 0.010 |
Why?
|
Neoplasm Metastasis | 3 | 1978 | 4915 | 0.010 |
Why?
|
Pulmonary Artery | 2 | 1978 | 1927 | 0.010 |
Why?
|
Natural Language Processing | 1 | 2006 | 1163 | 0.010 |
Why?
|
Models, Structural | 1 | 1977 | 340 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1978 | 413 | 0.010 |
Why?
|
Bayes Theorem | 2 | 1975 | 2330 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6075 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 1745 | 0.010 |
Why?
|
Thyroid Gland | 4 | 1984 | 1170 | 0.010 |
Why?
|
Knee Joint | 1 | 1986 | 1676 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1968 | 0.010 |
Why?
|
Nucleic Acid Precursors | 1 | 1976 | 15 | 0.010 |
Why?
|
Chromatography, Gel | 2 | 1974 | 646 | 0.010 |
Why?
|
Hydrogen | 1 | 1977 | 172 | 0.010 |
Why?
|
Serum Globulins | 1 | 1956 | 23 | 0.010 |
Why?
|
Prognosis | 4 | 1987 | 29629 | 0.010 |
Why?
|
Culture Techniques | 2 | 1968 | 531 | 0.010 |
Why?
|
Estradiol | 1 | 1984 | 1937 | 0.010 |
Why?
|
Hospital Design and Construction | 1 | 1976 | 33 | 0.010 |
Why?
|
Pelvimetry | 1 | 1976 | 6 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10554 | 0.010 |
Why?
|
Equipment and Supplies, Hospital | 1 | 1976 | 56 | 0.010 |
Why?
|
Xenon Radioisotopes | 1 | 1976 | 33 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1990 | 4937 | 0.010 |
Why?
|
Ceruloplasmin | 1 | 1956 | 56 | 0.010 |
Why?
|
Methylnitrosourea | 1 | 1996 | 30 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 891 | 0.010 |
Why?
|
Tin | 1 | 1975 | 13 | 0.010 |
Why?
|
Mammals | 1 | 1982 | 1132 | 0.010 |
Why?
|
Administration, Intravesical | 1 | 1996 | 92 | 0.010 |
Why?
|
Hepatectomy | 2 | 1971 | 557 | 0.010 |
Why?
|
Iodohippuric Acid | 1 | 1975 | 9 | 0.010 |
Why?
|
Deoxyuridine | 2 | 1982 | 34 | 0.010 |
Why?
|
Carbon Dioxide | 2 | 1978 | 1147 | 0.010 |
Why?
|
Health Facility Planning | 1 | 1975 | 19 | 0.010 |
Why?
|
Hospital Units | 1 | 1976 | 142 | 0.010 |
Why?
|
Biological Products | 1 | 1965 | 914 | 0.010 |
Why?
|
Hospital Planning | 1 | 1975 | 22 | 0.010 |
Why?
|
gamma-Globulins | 1 | 1975 | 119 | 0.010 |
Why?
|
Bone Resorption | 2 | 1978 | 723 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1998 | 290 | 0.010 |
Why?
|
Dipeptides | 1 | 1977 | 391 | 0.010 |
Why?
|
Information Theory | 1 | 1975 | 49 | 0.010 |
Why?
|
Tetracycline | 1 | 1976 | 216 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9280 | 0.010 |
Why?
|
Hepatitis B | 1 | 1981 | 705 | 0.010 |
Why?
|
Adult | 8 | 2008 | 221210 | 0.010 |
Why?
|
Proteomics | 1 | 2009 | 3848 | 0.010 |
Why?
|
Digoxin | 1 | 1976 | 246 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 1998 | 6214 | 0.010 |
Why?
|
Hospital Departments | 1 | 1975 | 134 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1996 | 232 | 0.010 |
Why?
|
Cineangiography | 1 | 1974 | 108 | 0.010 |
Why?
|
Bleomycin | 1 | 1976 | 494 | 0.010 |
Why?
|
Pyelonephritis | 1 | 1974 | 75 | 0.010 |
Why?
|
Lymphography | 1 | 1975 | 188 | 0.010 |
Why?
|
Metals | 1 | 1959 | 719 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 1 | 1976 | 337 | 0.010 |
Why?
|
Pyrimidines | 1 | 1967 | 3028 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1996 | 685 | 0.010 |
Why?
|
Patient Advocacy | 2 | 1989 | 360 | 0.010 |
Why?
|
Nucleotides | 2 | 1967 | 454 | 0.010 |
Why?
|
Breast Neoplasms | 5 | 2008 | 21019 | 0.010 |
Why?
|
Blood Platelets | 1 | 1965 | 2479 | 0.010 |
Why?
|
Consensus | 1 | 2004 | 3124 | 0.010 |
Why?
|
Regional Blood Flow | 2 | 1974 | 1496 | 0.010 |
Why?
|
Lymphoid Tissue | 2 | 1966 | 445 | 0.010 |
Why?
|
Blood | 1 | 1956 | 596 | 0.010 |
Why?
|
Carcinogens | 1 | 1996 | 452 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2008 | 5305 | 0.010 |
Why?
|
Lysine | 1 | 1998 | 993 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1973 | 182 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 7968 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1973 | 117 | 0.010 |
Why?
|
Mercury | 1 | 1995 | 290 | 0.010 |
Why?
|
Genomics | 1 | 2009 | 5821 | 0.010 |
Why?
|
Area Under Curve | 1 | 1997 | 1638 | 0.010 |
Why?
|
Colloids | 2 | 1984 | 123 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1971 | 81 | 0.010 |
Why?
|
Chromatography | 2 | 1972 | 189 | 0.010 |
Why?
|
Oxygen | 2 | 1982 | 4227 | 0.010 |
Why?
|
Cell Respiration | 1 | 1952 | 201 | 0.010 |
Why?
|
Spectrophotometry | 2 | 1972 | 309 | 0.010 |
Why?
|
Computers | 1 | 1974 | 593 | 0.010 |
Why?
|
Antitubercular Agents | 1 | 1980 | 1375 | 0.010 |
Why?
|
Chromatography, Paper | 2 | 1968 | 76 | 0.010 |
Why?
|
Immunologic Capping | 1 | 1991 | 30 | 0.010 |
Why?
|
Yeasts | 1 | 1952 | 279 | 0.010 |
Why?
|
Brain | 1 | 1998 | 27121 | 0.010 |
Why?
|
Videotape Recording | 1 | 1973 | 337 | 0.010 |
Why?
|
Research Design | 1 | 1987 | 6180 | 0.010 |
Why?
|
Goats | 1 | 1991 | 165 | 0.010 |
Why?
|
Ultraviolet Rays | 2 | 1973 | 1080 | 0.010 |
Why?
|
Radiation | 1 | 1990 | 49 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1990 | 69 | 0.010 |
Why?
|
Liver Regeneration | 1 | 1971 | 213 | 0.010 |
Why?
|
Adsorption | 1 | 1990 | 197 | 0.010 |
Why?
|
Morbidity | 1 | 1975 | 1752 | 0.010 |
Why?
|
Hyperparathyroidism | 3 | 1966 | 337 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 1989 | 138 | 0.010 |
Why?
|
Urinary Bladder | 1 | 1996 | 1152 | 0.010 |
Why?
|
Simplexvirus | 1 | 1973 | 803 | 0.010 |
Why?
|
Posture | 1 | 1974 | 957 | 0.010 |
Why?
|
Femoral Fractures | 1 | 1973 | 375 | 0.010 |
Why?
|
Right to Die | 1 | 1989 | 34 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2000 | 3113 | 0.010 |
Why?
|
Selenium Radioisotopes | 1 | 1988 | 13 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1990 | 321 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1991 | 718 | 0.010 |
Why?
|
Selenomethionine | 1 | 1988 | 18 | 0.010 |
Why?
|
Mitochondria | 1 | 1962 | 3624 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1975 | 2358 | 0.000 |
Why?
|
Jurisprudence | 1 | 1989 | 109 | 0.000 |
Why?
|
Euthanasia | 1 | 1989 | 58 | 0.000 |
Why?
|
Orotic Acid | 1 | 1968 | 24 | 0.000 |
Why?
|
Amino Acid Sequence | 2 | 1984 | 13446 | 0.000 |
Why?
|
Bismuth | 1 | 1988 | 29 | 0.000 |
Why?
|
Myocardial Infarction | 3 | 1984 | 11461 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 10766 | 0.000 |
Why?
|
Pain, Intractable | 1 | 1989 | 132 | 0.000 |
Why?
|
Uridine | 1 | 1968 | 141 | 0.000 |
Why?
|
Liver Extracts | 1 | 1967 | 6 | 0.000 |
Why?
|
Electrophoresis | 1 | 1967 | 227 | 0.000 |
Why?
|
Leukemia | 1 | 1976 | 1522 | 0.000 |
Why?
|
Phosphorus Isotopes | 1 | 1967 | 124 | 0.000 |
Why?
|
Tissue Extracts | 1 | 1967 | 141 | 0.000 |
Why?
|
Liver Diseases | 1 | 1975 | 1297 | 0.000 |
Why?
|
Thyroid Diseases | 1 | 1970 | 386 | 0.000 |
Why?
|
Risk Factors | 2 | 2010 | 74213 | 0.000 |
Why?
|
Organic Chemistry Phenomena | 1 | 1986 | 4 | 0.000 |
Why?
|
Aged | 8 | 1996 | 169310 | 0.000 |
Why?
|
Length of Stay | 1 | 1980 | 6426 | 0.000 |
Why?
|
Chemistry, Organic | 1 | 1986 | 9 | 0.000 |
Why?
|
Myocardium | 2 | 1977 | 4725 | 0.000 |
Why?
|
Bone Neoplasms | 1 | 1978 | 2529 | 0.000 |
Why?
|
Acute Disease | 2 | 1974 | 7237 | 0.000 |
Why?
|
RNA | 1 | 1975 | 2725 | 0.000 |
Why?
|
Mutation | 1 | 1990 | 30053 | 0.000 |
Why?
|
Fasting | 1 | 1971 | 1603 | 0.000 |
Why?
|
Alcoholism | 1 | 1976 | 1973 | 0.000 |
Why?
|
Mammography | 1 | 1976 | 2430 | 0.000 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1970 | 710 | 0.000 |
Why?
|
Patient Compliance | 1 | 1975 | 2690 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1996 | 5247 | 0.000 |
Why?
|
Public Policy | 1 | 1989 | 559 | 0.000 |
Why?
|
Microchemistry | 1 | 1984 | 54 | 0.000 |
Why?
|
Lysosomes | 1 | 1990 | 924 | 0.000 |
Why?
|
Centrifugation | 1 | 1984 | 122 | 0.000 |
Why?
|
Oils | 1 | 1984 | 56 | 0.000 |
Why?
|
Blood Proteins | 2 | 1966 | 1173 | 0.000 |
Why?
|
Chromatography, Gas | 1 | 1984 | 151 | 0.000 |
Why?
|
Mortality | 1 | 1975 | 2902 | 0.000 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1984 | 353 | 0.000 |
Why?
|
Pattern Recognition, Automated | 1 | 1970 | 997 | 0.000 |
Why?
|
Quantum Theory | 1 | 1983 | 69 | 0.000 |
Why?
|
Ouabain | 1 | 1983 | 247 | 0.000 |
Why?
|
Physician-Patient Relations | 2 | 1989 | 3251 | 0.000 |
Why?
|
Middle Aged | 7 | 1996 | 220921 | 0.000 |
Why?
|
Parathyroid Glands | 1 | 1965 | 518 | 0.000 |
Why?
|
Binding, Competitive | 1 | 1984 | 1141 | 0.000 |
Why?
|
Health Expenditures | 1 | 1975 | 2366 | 0.000 |
Why?
|
Thyrotropin | 1 | 1966 | 834 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1998 | 4024 | 0.000 |
Why?
|
Thyroxine | 1 | 1966 | 666 | 0.000 |
Why?
|
Life Support Care | 1 | 1984 | 226 | 0.000 |
Why?
|
Coronary Angiography | 1 | 1974 | 4471 | 0.000 |
Why?
|
Home Care Services | 1 | 1989 | 648 | 0.000 |
Why?
|
Acute Kidney Injury | 1 | 1974 | 1924 | 0.000 |
Why?
|
Pathology | 1 | 1965 | 270 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1974 | 17635 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1973 | 3096 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1952 | 2688 | 0.000 |
Why?
|
Nursing Homes | 1 | 1989 | 1082 | 0.000 |
Why?
|
Body Weight | 1 | 1971 | 4618 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1984 | 1122 | 0.000 |
Why?
|
Temperature | 2 | 1983 | 2226 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1976 | 12973 | 0.000 |
Why?
|
Chromium | 1 | 1981 | 132 | 0.000 |
Why?
|
Blood Pressure | 1 | 1975 | 8481 | 0.000 |
Why?
|
Particle Size | 1 | 1984 | 1648 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1990 | 3769 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1980 | 659 | 0.000 |
Why?
|
Drug Interactions | 1 | 1984 | 1416 | 0.000 |
Why?
|
Cattle | 1 | 1965 | 3849 | 0.000 |
Why?
|
Survival Analysis | 1 | 1991 | 10090 | 0.000 |
Why?
|
Cesium Radioisotopes | 1 | 1978 | 38 | 0.000 |
Why?
|
Patient Care Planning | 1 | 1984 | 909 | 0.000 |
Why?
|
Suicide | 1 | 1989 | 1602 | 0.000 |
Why?
|
Glucose | 1 | 1970 | 4347 | 0.000 |
Why?
|
Patients | 1 | 1984 | 907 | 0.000 |
Why?
|
Phosphates | 1 | 1981 | 770 | 0.000 |
Why?
|
Enzyme Activation | 2 | 1973 | 3597 | 0.000 |
Why?
|
Erythrocytes | 1 | 1966 | 2413 | 0.000 |
Why?
|
Intestinal Mucosa | 2 | 1984 | 3032 | 0.000 |
Why?
|
Software | 1 | 1990 | 4434 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1983 | 2009 | 0.000 |
Why?
|
Immune Sera | 1 | 1975 | 606 | 0.000 |
Why?
|
Patient Participation | 1 | 1984 | 1445 | 0.000 |
Why?
|
Age Factors | 1 | 1971 | 18399 | 0.000 |
Why?
|
Maxilla | 1 | 1978 | 494 | 0.000 |
Why?
|
Asthma | 1 | 1973 | 6234 | 0.000 |
Why?
|
Hypertension | 1 | 1974 | 8540 | 0.000 |
Why?
|
Aminopterin | 1 | 1973 | 15 | 0.000 |
Why?
|
Hypoxanthines | 1 | 1973 | 35 | 0.000 |
Why?
|
Pulmonary Heart Disease | 1 | 1973 | 34 | 0.000 |
Why?
|
Muscles | 2 | 1970 | 1576 | 0.000 |
Why?
|
Serum Albumin | 2 | 1967 | 672 | 0.000 |
Why?
|
Pelvic Neoplasms | 1 | 1975 | 247 | 0.000 |
Why?
|
Mandible | 1 | 1978 | 753 | 0.000 |
Why?
|
Bromodeoxyuridine | 1 | 1973 | 311 | 0.000 |
Why?
|
Nucleic Acid Denaturation | 1 | 1972 | 110 | 0.000 |
Why?
|
Alcohols | 1 | 1972 | 94 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1981 | 4807 | 0.000 |
Why?
|
Ferritins | 1 | 1975 | 598 | 0.000 |
Why?
|
Adolescent | 3 | 1976 | 88326 | 0.000 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1978 | 926 | 0.000 |
Why?
|
Lectins | 1 | 1973 | 491 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1978 | 2915 | 0.000 |
Why?
|
Bone Regeneration | 1 | 1973 | 432 | 0.000 |
Why?
|
Autopsy | 1 | 1973 | 1009 | 0.000 |
Why?
|
Dementia | 1 | 1984 | 2689 | 0.000 |
Why?
|
Glycogen | 1 | 1970 | 251 | 0.000 |
Why?
|
Hospitalization | 1 | 1989 | 10721 | 0.000 |
Why?
|
Serum Albumin, Radio-Iodinated | 1 | 1967 | 37 | 0.000 |
Why?
|
Cystine | 1 | 1967 | 94 | 0.000 |
Why?
|
Trichloroacetic Acid | 1 | 1966 | 48 | 0.000 |
Why?
|
Physicians | 1 | 1984 | 4591 | 0.000 |
Why?
|
Triiodothyronine | 1 | 1966 | 493 | 0.000 |
Why?
|
Adipose Tissue, Brown | 1 | 1970 | 764 | 0.000 |
Why?
|
Adrenal Glands | 1 | 1966 | 552 | 0.000 |
Why?
|
Proteins | 2 | 1970 | 6032 | 0.000 |
Why?
|
Fibrinogen | 1 | 1966 | 888 | 0.000 |
Why?
|
Cysteine | 1 | 1967 | 891 | 0.000 |
Why?
|
Fatty Acids | 1 | 1970 | 1808 | 0.000 |
Why?
|
Organ Size | 1 | 1966 | 2254 | 0.000 |
Why?
|
Recurrence | 1 | 1973 | 8466 | 0.000 |
Why?
|
Thymus Gland | 1 | 1965 | 1243 | 0.000 |
Why?
|
Hemoglobins | 1 | 1966 | 1526 | 0.000 |
Why?
|
Lipids | 1 | 1970 | 3341 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1970 | 3313 | 0.000 |
Why?
|
Bone Marrow | 1 | 1966 | 2911 | 0.000 |
Why?
|
Blood Glucose | 1 | 1970 | 6391 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1973 | 39106 | 0.000 |
Why?
|
Heart Failure | 1 | 1973 | 11671 | 0.000 |
Why?
|